Breast and gynecological cancers in Croatia, 1988-2008

Croatian Medical Journal

Volumn 53, Issue 2, 2012, Pages 100-108

  Kelava, Iva ^a   Tomičić, Karlo ^b   Kokić, Marina ^c   Ćorušić, Ante ^b   Planinić, Pavao ^b   Kirac, Iva ^d   Murgić, Jure ^d   Kuliš, Tomislav ^b   Znaor, Ariana ^e,f  

^a Croatia   (Croatia)

^b KBC Zagreb   (Croatia)

^c Health Centre Zagreb (East)   (Croatia)

^d SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^e UNIVERSITY OF ZAGREB   (Croatia)

^f CROATIAN NATIONAL INSTITUTE OF PUBLIC HEALTH   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CROATIA; ENDOMETRIUM CANCER; FEMALE; GROUPS BY AGE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; TREND STUDY; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CROATIA; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; MIDDLE AGED; MORBIDITY; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84862562551     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2012.53.100     Document Type: Article

References (54)

1. Croatian National Cancer Registry. Cancer incidence in Croatia 2008. Bulletin No 33. Zagreb: Croatian National Institute of Public Health; 2010.
2. Rieck G, Fiander A. The effect of lifestyle factors on gynaecological cancer. Best Pract Res Clin Obstet Gynaecol. 2006;20:227-51.
3. Chiaffarino F, Pelucchi C, Parazzini F, Negri E, Franceschi S, Talamini R, et al. Reproductive and hormonal factors and ovarian cancer. Ann Oncol. 2001;12:337-41.
4. Parsa P, Parsa B. Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac J Cancer Prev. 2009;10:545-50.
5. Elwood JM, Cole P, Rothman KJ, Kaplan SD. Epidemiology of endometrial cancer. J Natl Cancer Inst. 1977;59:1055-60.
6. Yadav BS, Sharma SC, Patel FD, Ghoshal S, Kapoor R, Kumar R. Nonbreast second malignancies after treatment of primary breast cancer. Int J Radiat Oncol Biol Phys. 2009;73:1489-92.
7. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev. 2007;16:276-80.
8. Suh S, Kim KW. Diabetes and cancer: is diabetes causally related to cancer? Diabetes Metab J. 2011;35:193-8.
9. Williams-Brown MY, Salih SM, Xu X, Veenstra TD, Saeed M, Theiler SK, et al. The effect of tamoxifen and raloxifene on estrogen metabolism and endometrial cancer risk. J Steroid Biochem Mol Biol. 2011;126:78-86.
10. Vessey MP, Painter R. Endometrial and ovarian cancer and oral contraceptives- findings in a large cohort study. Br J Cancer. 1995;71:1340-2.
11. Viswanathan AN, Feskanich D, De Vivo I, Hunter DJ, Barbieri RL, Rosner B, et al. Smoking and the risk of endometrial cancer: results from the Nurses' Health Study. Int J Cancer. 2005;114:996-1001.
12. Zhou B, Yang L, Sun Q, Cong R, Gu H, Tang N, et al. Cigarette smoking and the risk of endometrial cancer: a meta-analysis. Am J Med. 2008;121:501-8e3.
13. Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, et al. Oral contraceptives and breast cancer risk among younger women. J Natl Cancer Inst. 1995;87:827-35.
14. Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009;360:573-87.
15. Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst. 2004;96:1635-8.
16. Inumaru LE, Silveira EA, Naves MM. Risk and protective factors for breast cancer: a systematic review. Cad Saude Publica. 2011;27:1259-70.
17. Appleby P, Beral V, Berrington de Gonzalez A, Colin D, Franceschi S, Goodill A, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer. 2006;118:1481-95.
18. Collins S, Rollason TP, Young LS, Woodman CB. Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: a longitudinal study. Eur J Cancer. 2010;46:405-11.
19. de Sanjose S, Bosch FX, Munoz N, Shah K. Social differences in sexual behaviour and cervical cancer. IARC Sci Publ. 1997;(138):309-17.
20. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer. 2000;83:1565-72.
21. Hakama M, Luostarinen T, Hallmans G, Jellum E, Koskela P, Lehtinen M, et al. Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries). Cancer Causes Control. 2000;11:783-90.
22. Ludicke F, Stalberg A, Vassilakos P, Major AL, Campana A. High- and intermediate-risk human papillomavirus infection in sexually active adolescent females. J Pediatr Adolesc Gynecol. 2001;14:171-4.
23. Smith JS, Bosetti C, Munoz N, Herrero R, Bosch FX, Eluf-Neto J, et al. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004;111:431-9.
24. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA. 2001;286:3106-14.
25. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer incidence in five continents. Vol. VIII (IARC Scientific Publications No. 155). Lyon (France): IARC; 2002.
26. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors. Cancer incidence in five continents. Vol. VII (IARC Scientific Publications No. 143). Lyon (France): IARC; 1997.
27. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al, editors. Cancer incidence in five continents. Vol. IX (IARC Scientific Publications No. 160). Lyon (France): IARC; 2007.
28. World Health Organization. World Health Organization, mortality database. WHO Statistical Information System. Available from: http://www.who.int/whosis/mort/download/en/index.html. Accessed: March 26, 2012.
29. Doll R, Payne P, Waterhouse JAH, editors. Cancer incidence in five continents. Vol. I. Geneva (Switzerland): Union Internationale Contre le Cancer; 1966.
30. United Nations. World population prospects, the 2010 revision. United Nations Population Division Department of Economic and Social Affairs. Available from: http://esa.un.org/unpd/wpp/index.htm. Accessed: March 26, 2012.
31. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335-51.
32. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLO BOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon (France): International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr. Accessd: March 5, 2012.
33. Hery C, Ferlay J, Boniol M, Autier P. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol. 2008;19:1187-94.
34. Country profile - Croatia. Available from: http://apps.who.int/nutrition/landscape/report.aspx?iso=hrv. Accessed: March 5, 2012.
35. Croatia National Institute of Public Health. Croatian health service yearbook 2010. Zagreb: Croatian National Institute of Public Health; 2010.
36. Fistonic I, Srecko C, Marina F, Ivan S. Menopause in Croatia. Sociodemographic characteristics, women's attitudes and source of information, compliance with HRT. Maturitas. 2004;47:91-8.
37. Godeau E, Nic Gabhainn S, Vignes C, Ross J, Boyce W, Todd J. Contraceptive use by 15-year-old students at their last sexual intercourse: results from 24 countries. Arch Pediatr Adolesc Med. 2008;162:66-73.
38. World Health Organization. Global Status Report on Alcohol 2004. Available from: http://www.who.int/substance_abuse/publications/alcohol/en/. Accessed: March 5, 2012.
39. Služba za epidemiologiju kronicnih masovnih bolesti. Available from: http://www.hzjz.hr/epidemiologija/kron_mas/prev_mamma.htm. Accessed: April 20, 2012.
40. Sarkeala T, Heinavaara S, Anttila A. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. Int J Cancer. 2008;122:614-9.
41. Schopper D, de Wolf C. How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer. 2009;45:1916-23.
42. Botha JL, Bray F, Sankila R, Parkin DM. Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003;39:1718-29.
43. Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev. 2005;14:1132-42.
44. Bray F, Loos AH, Tognazzo S, La Vecchia C. Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer. 2005;113:977-90.
45. Heim I, Leontic K, Gostovic MJ. Obesity and overweight in Croatia [in Croatian]. Acta Med Croatica. 2007;61:267-73.
46. Metelko Z, Pavlic-Renar I, Poljicanin T, Szirovitza L, Turek S. Prevalence of diabetes mellitus in Croatia. Diabetes Res Clin Pract. 2008;81:263-7.
47. Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer. 2008;44:1345-89.
48. Arbyn M, Autier P, Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol. 2007;18:1423-5.
49. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. Arch Pathol Lab Med. 1997;121:211-24.
50. Znaor A, Strnad M. Cervical cancer in Croatia: state of the art and possibilities for prevention. Coll Antropol. 2007;31 Suppl 2:37-40.
51. Anttila A, Nieminen P. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol. 2007;31 Suppl 2:17-22.
52. Gissmann L, Muller M. Development of prophylactic HPV vaccines. Coll Antropol. 2007;31 Suppl 2:113-5.
53. Kaic B, Gjenero-Margan I, Brzovic M, Lakoseljac D, Aleraj B, Nemeth-Blazic T, et al. Vaccine regulations in Croatia. Coll Antropol. 2007;31 Suppl 2:117-20.
54. Franco EL, Cuzick J, Hildesheim A, de Sanjose S. Chapter 20: issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine. 2006;24 Suppl 3:S3/171-7.